You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Portal vein thrombosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Portal Vein Thrombosis in Children

Not yet recruiting
  • Portal Vein Thrombosis
  • endoscopy
  • (no location specified)
Nov 3, 2023

Portal Vein Thrombosis in Neonate With Umbilical Catheter

Not yet recruiting
  • Portal Vein Thrombosis
  • ultrasound and doppler
  • (no location specified)
Nov 21, 2023

Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • Recombinant human adenovirus type 5 + TACE
  • (no location specified)
May 14, 2023

Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding Trial in Chengdu (preemptive TIPS, standard second

Not yet recruiting
  • Portal Hypertension
  • +3 more
  • preemptive TIPS
  • standard second prophylaxis
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 3, 2023

HCC With Portal Vein Tumor Thrombosis on Basis of Risk Scoring

Completed
  • Hepatocellular Carcinoma
  • +2 more
    • Daegu, DalSeo-gu, Korea, Republic of
      Keimyung university Dongsan Medical Center
    Aug 16, 2023

    A Practical Nomogram Based on Systemic Inflammatory Markers for

    Completed
    • Systemic Inflammatory Markers
    • Portal Vein Thrombosis
    • clinical laboratory tests, and imaging characteristics
    • Qingdao, Shandong, China
      the Affiliated Hospital of Qingdao University
    Sep 13, 2022

    Deep Vein Thrombosis, Chronic Portal Vein Thrombosis Trial in Clichy (Xarelto)

    Completed
    • Deep Vein Thrombosis
    • Chronic Portal Vein Thrombosis
    • Clichy, France
      Hôpital Beaujon
    Jul 22, 2022

    Unresectable Hepatocellular Carcinoma, Pembrolizumab, Lenvatinib Trial in Taipei City (Lenvatinib/Pembrolizumab plus SBRT

    Not yet recruiting
    • Unresectable Hepatocellular Carcinoma
    • +3 more
    • Lenvatinib/Pembrolizumab plus SBRT combinations
    • Taipei City, Taiawn, Taiwan
      National Taiwan University Hospital
    Jan 30, 2023

    Hepatocellular Carcinoma Portal Vein Thrombosis After

    Not yet recruiting
    • Hepatocellular Carcinoma
    • trans arterial chemoembolization
    • (no location specified)
    Aug 4, 2022

    Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Portal Vein Thrombosis
    • PBT and atezolizumab/bevacizumab
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Nov 15, 2022

    Recurrence of Thrombosis or Thrombotic Extension, in Event of

    Completed
    • Portal Vein Thrombosis
    • Local Cause
      • Caen, Calvados, France
        Chu de Caen
      Apr 29, 2022

      Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

      Recruiting
      • Cirrhosis
      • +3 more
      • Apixaban 2.5 MG
      • +2 more
      • Yangzhou, Jiangsu, China
        Clinical Medical College, Yangzhou University
      Apr 30, 2022

      Portal Vein Thrombosis, Cirrhosis, Liver Trial in Hershey (Antithrombin III, Placebo)

      Withdrawn
      • Portal Vein Thrombosis
      • Cirrhosis, Liver
      • Antithrombin III
      • Placebo
      • Hershey, Pennsylvania
        Penn State College of Medicine
      Feb 23, 2022

      Liver Cirrhosis, Portal Hypertension, Non-Cirrhotic Portal Hypertension Trial in Freiburg (Implantation of a transjugular

      Recruiting
      • Liver Cirrhosis
      • +5 more
      • Implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
      • Freiburg, Germany
        University Medical Center Freiburg, Department of Medicine II
      Mar 22, 2023

      Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

      Recruiting
      • Cirrhosis
      • +3 more
      • Yangzhou, Jiangsu, China
        Clinical Medical College of Yangzhou University
      Mar 19, 2022

      Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis

      Recruiting
      • Liver Cirrhosis
      • +4 more
      • Somatostatin and its analogs
      • Endoscopic sclerotherapy, endoscopic variceal ligation, endoscopic tissue glue injection
      • Shenyang, Liaoning, China
        Department of Gastroenterology, General Hospital of Shenyang Mil
      Mar 17, 2022

      Living Donor Liver Transplantation to Portal Vein Thrombosis

      Completed
      • Portal Vein Thrombosis
      • Liver Transplant; Complications
      • living donor liver transplantation
      • Thrombectomy or interposition graft
      • (no location specified)
      Nov 19, 2021

      Portal Vein Thrombosis and Budd-Chiari Syndrome

      Recruiting
      • Hepatic Vein Thromboses
      • +9 more
      • Rotational thromboelastometry
      • +2 more
      • Chandigarh, Choose Any State/Province, India
        Postgraduate Institute of Medical Education and Research
      Nov 5, 2021

      Cirrhosis, Portal Vein Thrombosis, Esophageal and Gastric Varices Trial in Jinan (nadroparin calcium-warfarin sequential

      Completed
      • Cirrhosis
      • +3 more
      • nadroparin calcium-warfarin sequential anticoagulation
      • Jinan, Shandong, China
        Department of Gastroenterology,Qilu Hospital,Shandong University
      Jul 3, 2022

      Neutrophil Extracellular Trap Formation, Portal Vein Thrombosis, Liver Cirrhosis Trial in Qingdao (test NETs markers)

      Completed
      • Neutrophil Extracellular Trap Formation
      • +2 more
      • test NETs markers
      • Qingdao, Shandong, China
        the Affiliated Hospital of Qingdao University
      Aug 12, 2021

      Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Lenvatinib, Transarterial Chemoembolization (TACE))

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Wuhan, Hubei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      Oct 17, 2023

      Liver Cirrhosis, Portal Vein Thrombosis Trial in New Delhi (Dabigatran, Placebo)

      Recruiting
      • Liver Cirrhosis
      • Portal Vein Thrombosis
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Aug 19, 2021

      HepatoCellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Sorafenib)

      Completed
      • HepatoCellular Carcinoma
      • Portal Vein Thrombosis
      • Beijing, Beijing, China
        Peking University Cancer Hospital
      Oct 8, 2021

      Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Beijing (HAIC, Lenvatinib 1, Camrelizumab 1)

      Recruiting
      • Hepatocellular Carcinoma
      • Portal Vein Thrombosis
      • HAIC
      • +4 more
      • Beijing, Beijing, China
        Peking Univerisity Cancer Hospital
      Jan 10, 2022

      Liver Cancer, Liver Transplant; Complications, Hepatocellular Carcinoma Trial in Shanghai (radiation, combination product, drug)

      Not yet recruiting
      • Liver Cancer
      • +4 more
      • intensity-modulated radiotherapy
      • +5 more
      • Shanghai, China
        Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
      Apr 20, 2022